Oncotarget

Research Perspectives:

Zebrafish B cell acute lymphoblastic leukemia: new findings in an old model

Gilseung Park, Jessica Burroughs-Garcia, Clay A. Foster, Ameera Hasan, Chiara Borga and J. Kimble Frazer _

PDF  |  Full Text  |  Supplementary Files  |  How to cite  |  Press Release  |  Order a Reprint

Oncotarget. 2020; 11:1292-1305. https://doi.org/10.18632/oncotarget.27555

Metrics: PDF 643 views  |   Full Text 968 views  |   ?  


Abstract

Gilseung Park1,*, Jessica Burroughs-Garcia2,*, Clay A. Foster3,*, Ameera Hasan4, Chiara Borga2 and J. Kimble Frazer1,2,4

1 Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

2 Department of Pediatrics, Section of Pediatric Hematology-Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

3 Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599, USA

4 Department of Microbiology & Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

* These authors contributed equally to this work

Correspondence to:

J. Kimble Frazer,email: Kimble-Frazer@ouhsc.edu

Keywords: acute lymphoblastic leukemia; ALL; zebrafish; lymphocyte; MYC

Received: November 13, 2019     Accepted: March 19, 2020     Published: April 14, 2020

ABSTRACT

Acute lymphoblastic leukemia (ALL) is the most common pediatric, and ninth most common adult, cancer. ALL can develop in either B or T lymphocytes, but B-lineage ALL (B-ALL) exceeds T-ALL clinically. As for other cancers, animal models allow study of the molecular mechanisms driving ALL. Several zebrafish (Danio rerio) T-ALL models have been reported, but until recently, robust D. rerio B-ALL models were not described. Then, D. rerio B-ALL was discovered in two related zebrafish transgenic lines; both were already known to develop T-ALL. Here, we report new B-ALL findings in one of these models, fish expressing transgenic human MYC (hMYC). We describe B-ALL incidence in a large cohort of hMYC fish, and show B-ALL in two new lines where T-ALL does not interfere with B-ALL detection. We also demonstrate B-ALL responses to steroid and radiation treatments, which effect ALL remissions, but are usually followed by prompt relapses. Finally, we report gene expression in zebrafish B lymphocytes and B-ALL, in both bulk samples and single B- and T-ALL cells. Using these gene expression profiles, we compare differences between the two new D. rerio B-ALL models, which are both driven by transgenic mammalian MYC oncoproteins. Collectively, these new data expand the utility of this new vertebrate B-ALL model.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27555